This Tuesday morning symposium, organized by Dwight Stoll of Gustavus Adolphus College, brings together experts in liquid chromatography (LC) to discuss recent advances in two dimensional (2D)-LC separations of small and large molecules. Different perspectives from instrument manufacturers, users in the pharmaceutical industry, and academic laboratories will be presented as well as a discussion on some samples related to pharmaceutical and biopharmaceutical applications.
Session 760
Room 311AB
8:30–11:45 a.m.
This Tuesday morning symposium, organized by Dwight Stoll of Gustavus Adolphus College, brings together experts in liquid chromatography (LC) to discuss recent advances in two dimensional (2D)-LC separations of small and large molecules. Different perspectives from instrument manufacturers, users in the pharmaceutical industry, and academic laboratories will be presented as well as a discussion on some samples related to pharmaceutical and biopharmaceutical applications.
The first talk will be given by Stoll and is titled “Development of Active Solvent Modulation as a Versatile Approach to Improve the Compatibility of Different Separation Modes Used in 2D-LC.” In this presentation, Stoll will describe recent insights on the utility active solvent modulation (ASM) obtained from both simulations and experiments. In addition, he will present results of representative 2D-LC separations of peptides and proteins that illustrate the utility of the ASM approach.
The next talk will be given by Brooke M. Koshel of Waters Corporation titled “Two-Dimensional Liquid Chromatography Coupled to Mass Spectrometry for Impurity Analysis of Oligonucleotides.” In this presentation, modified oligonucleotides will be analyzed using 2D-LC coupled to mass spectrometry (MS) to address the challenges faced when selecting a mobile phase to optimize both chromatography and mass spectrometry. By incorporating a second-dimension separation and at-column-dilution, sensitivity is improved to detect impurities that are not readily detectable through one-dimensional chromatography alone.
The third talk is titled “Enantioselective Analysis Using Multidimensional Liquid Chromatography,” and will be presented by Jeannie Horak of the University of Tuebingen. In this presentation, the different modalities of enantioselective multidimensional LC, such as offline LCxLC, online multiple heart cutting, high resolution sampling (selective comprehensive), and fully comprehensive LCxLC, will be discussed. The advantages, challenges, problems and how they can be overcome, and disadvantages of each modality will be outlined by Horak using real applications from pharmaceutical analysis to biotechnology.
After a brief recess, Stephan Buckenmaier of Agilent Technologies will present a talk titled “Improvements in 2D-LC Applications Enabled by New Instrument Technology.” This presentation will focus on a technique referred to as multiple heart-cutting 2D-LC, which breaks the link between the 1D and 2D separation timescales allowing for operation of both dimensions nearly independently.
The final talk in this session is titled “Characterization of Biocompatible Polymers for Drug Conjugation by 2DLC-QTOF,” and will be presented by Kelly Zhang of Genentech. Zhang will discuss the use of 2DLC-QTOF with charge reduction mass spectrometry to deconvolute the polymer distributions to lower charge states to identify and characterize the heterogenous polymer profile and its maleimide related species.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.